# Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders

> **NCT02946658** · PHASE1,PHASE2 · SUSPENDED · sponsor: **Healeon Medical Inc** · enrollment: 100 (estimated)

## Conditions studied

- Lung Disease

## Interventions

- **PROCEDURE:** lipoaspiration
- **PROCEDURE:** ADcSVF
- **PROCEDURE:** Normal Saline IV

## Key facts

- **NCT ID:** NCT02946658
- **Lead sponsor:** Healeon Medical Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2016-10
- **Primary completion:** 2026-08-14
- **Final completion:** 2027-08-14
- **Target enrollment:** 100 (ESTIMATED)
- **Why stopped:** COVID-19 stopped patient ability to complete access for outcome analysis
- **Last updated:** 2025-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02946658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02946658, "Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02946658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*